Form 4: Aura Biosciences SVP of Finance Sells Shares to Cover Tax Obligations

Amy Elazzouzi, Senior Vice President of Finance at Aura Biosciences, sold 1,404 shares of common stock on February 18, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 18, 2025, Amy Elazzouzi, Senior Vice President of Finance at Aura Biosciences, sold 1,404 shares of Aura Biosciences common stock.
• The shares were sold at a price of $7.75 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Elazzouzi directly owns 82,278 shares of Aura Biosciences common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, with no indication of positive or negative implications for the company's performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.

Stakeholder Impact

• The sale has a minimal impact on shareholders as it is a small transaction related to tax obligations.

Key Dates

Keywords

Aura Biosciences, AURA, Amy Elazzouzi, Form 4, insider trading, stock sale, restricted stock units, tax withholding